Mahmood Alam COSA-IPOS Joint Scientific Meeting 2012

Abstracts this author is presenting:

• Progression free survival vs overall survival: An example from randomised phase III trial with Axitinib (AXIS) in metastatic renal cell carcinoma — COSA Posters: Clinical Research
• A personalised approach to treating cancer; a cross-sectional review to understand public perception and its capacity to influence clinical outcomes — COSA Posters: Clinical Research